Wells Fargo & Company Forecasts Strong Price Appreciation for Ventas (NYSE:VTR) Stock

Ventas (NYSE:VTR) had its price target hoisted by equities researchers at Wells Fargo & Company from $88.00 to $93.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target would indicate a potential upside of 13.41% from the stock’s previous close.

A number of other analysts have also commented on the company. Citigroup lifted their target price on Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 price objective on shares of Ventas in a research report on Monday, February 9th. Mizuho lifted their price objective on Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, March 4th. JPMorgan Chase & Co. boosted their target price on Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research report on Friday, March 20th. Finally, Scotiabank upped their target price on shares of Ventas from $80.00 to $93.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Ventas presently has an average rating of “Moderate Buy” and a consensus target price of $90.47.

Ventas Trading Down 0.8%

NYSE:VTR opened at $82.00 on Thursday. The company’s 50 day moving average price is $83.04 and its 200-day moving average price is $77.46. Ventas has a 52 week low of $60.15 and a 52 week high of $88.36. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The stock has a market cap of $38.95 billion, a price-to-earnings ratio of 151.86, a PEG ratio of 2.04 and a beta of 0.73.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. Ventas’s revenue was up 21.7% on a year-over-year basis. During the same period last year, the business earned $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, equities research analysts forecast that Ventas will post 3.4 earnings per share for the current fiscal year.

Insider Transactions at Ventas

In related news, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at $6,184,175. The trade was a 32.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the sale, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at $10,694,026.50. The trade was a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 86,106 shares of company stock worth $6,931,397 in the last ninety days. Insiders own 0.80% of the company’s stock.

Institutional Investors Weigh In On Ventas

A number of large investors have recently made changes to their positions in VTR. Vanguard Group Inc. increased its position in shares of Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after purchasing an additional 2,349,176 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Ventas by 1.3% in the third quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after buying an additional 387,495 shares during the last quarter. State Street Corp boosted its holdings in shares of Ventas by 2.5% in the fourth quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after buying an additional 735,620 shares during the last quarter. Geode Capital Management LLC grew its position in Ventas by 3.8% during the fourth quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock valued at $1,001,447,000 after buying an additional 475,633 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its holdings in Ventas by 27.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock valued at $710,060,000 after buying an additional 2,000,341 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.